InvestorLens

NVO — NOVO-NORDISK A S

Health Care · Drug Manufacturers

Sign in to save4 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About NOVO-NORDISK A S (NVO)

NOVO-NORDISK A S (NVO) appears in the most recent 13F filings of 4 tracked institutional investors. NOVO-NORDISK A S is classified in the Health Care sector (Drug Manufacturers industry). The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $1.6B. Across recent filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in NVO

100
/100
Strong Institutional Accumulation
Added / Increased1
Reduced0
Exited0
BearishBullish
Crowded Trade Score™

How many top investors track NVO

27
/100
Emerging Interest
4investors

A small number of top investors own this.

UndiscoveredCrowded
151015+

NVO Ownership Composition

How NOVO-NORDISK A S is held across tracked investor types, based on reported 13F positions.

Dominant Type
Other
93% of tracked value
Institutions
4
tracked investors
Total Reported
$924.5M
combined 13F value
Sectors2
  • Other92.9%
  • Hedge Funds7.1%
Other(3)
92.9%
Hedge Funds(1)
7.1%

Tracked investors reporting NVO

  • Ken GriffinMar 31, 2026
    Citadel Advisors
    Shares
    20.1M
    Value
    $740.1M
    % Portfolio
    0.12%
  • Izzy EnglanderMar 31, 2026
    Millennium Management
    Shares
    3M
    Value
    $111.2M
    % Portfolio
    0.05%
  • Steve CohenMar 31, 2026
    Point72 Asset Management
    Shares
    1.8M
    Value
    $65.5M
    % Portfolio
    0.08%
  • Ray DalioSep 30, 2025
    Bridgewater Associates
    Shares
    138.9K
    Value
    $7.7M
    % Portfolio
    0.10%

Recent activity

Frequently asked questions

How many institutional investors hold NVO?
4 tracked institutional investors disclosed a position in NVO (NOVO-NORDISK A S) in their most recent 13F filing.
Who is the largest institutional holder of NVO?
Ken Griffin, Citadel Advisors, holds the largest disclosed position in NVO, valued at $1.6B.
Did institutional ownership of NVO increase or decrease?
Across recent 13F filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 fully exited NVO.
What sector is NVO in?
NOVO-NORDISK A S is classified in the Health Care GICS sector, Drug Manufacturers industry.
Where does this NVO ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.
NVO (NOVO-NORDISK A S) — Institutional Holders & 13F History — InvestorLens